Skip to content

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Reducing Unsafe Drinking in HIV Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00371969
Enrollment
254
Registered
2006-09-04
Start date
2006-10-31
Completion date
2011-10-31
Last updated
2015-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse

Keywords

Unsafe drinking, Human Immunodeficiency Virus, Motivational Interviewing

Brief summary

The main aim of this study is to test an intervention to reduce unsafe drinking among HIV-positive primary care patients. The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system). Subjects who receive the enhanced motivational interview are expected to show greater improvements in drinking than individuals who receive the standard motivational interview or view a DVD on HIV self-care.

Detailed description

HIV infection is a widespread health problem in the U.S. Antiretroviral treatment has increased longevity and changed the nature of risk factors for morbidity and mortality. Alcohol consumption has become an increasingly serious health issue among HIV primary care patients. Drinking is a key factor in progression to severe liver damage (especially those co-infected with hepatitis), and liver disease is now one of the most common causes of death among those with HIV. Excess drinking is also associated with medication noncompliance, reduces the effect of antiretroviral treatment, and is linked to other health problems. Therefore, helping HIV patients reduce unsafe drinking is crucial to their long-term health. The intervention combines the brief MI, an established, evidence-based counseling approach, with an innovative procedure designed to strengthen the effects of the MI. An effective, easily implemented alcohol-reduction intervention could be incorporated into standard care in HIV clinics helping prevent or slow the progress of some medical problems in HIV-infected individuals, improve medication compliance, prolong lifespan and decrease risk behavior associated with alcohol use. Comparison(s): Enhanced brief motivational interview (including an IVR component for alcohol self-monitoring purposes), brief motivational interview, viewing a DVD on HIV self-care.

Interventions

BEHAVIORALEnhanced Motivational Interview

The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system).

BEHAVIORALStandard Motivational Interview or viewing DVD

Brief motivational interview, viewing a DVD on HIV self-care.

Sponsors

Research Foundation for Mental Hygiene, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male and females 18 years of age or older. * Participants have had 4 or more drinks on any day in the prior 30 days assessed via standardized questions. * Participants are referred to a study MI counselor by clinic staff as needing an intervention for drinking * Participants agree to random assignment and provide informed consent

Exclusion criteria

* Participants who are currently psychotic, suicidal or homicidal. * Participants who have definite plans to leave the greater New York metropolitan area within the study period. * Participants who demonstrate gross cognitive impairment as evidenced on the Halstead-Reitain Trails (A). * Participants who do not speak English or Spanish, or have hearing impairments that preclude use of the telephone.

Design outcomes

Primary

MeasureTime frameDescription
Alcohol consumption in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed.Baseline, 30, 60 days (end-of-treatment), 3, 6, 12 monthsAs measured by number of drinks per drinking day and percentage of days abstinent.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026